Items where authors include "Khanna, D."

Article

Álvarez-Hernández, M.P. orcid.org/0000-0002-9972-1312, Allanore, Y., Andrade, I. et al. (9 more authors) (2024) Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: A survey of UK-based rheumatologists. Journal of Scleroderma and Related Disorders. ISSN 2397-1983

Foeldvari, I. orcid.org/0000-0003-0659-5298, Torok, K.S., Anton, J. orcid.org/0000-0002-8792-4219 et al. (23 more authors) (2023) Proposed Response Parameters for Twelve-Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings. Arthritis Care & Research, 75 (12). pp. 2453-2462. ISSN 2151-464X

Lescoat, A., Bellando-Randone, S., Campochiaro, C. et al. (9 more authors) (2023) Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine. The Lancet Rheumatology, 5 (11). e683-e694. ISSN 2665-9913

Spiera, R. orcid.org/0000-0003-2911-6800, Kuwana, M. orcid.org/0000-0001-8352-6136, Khanna, D. orcid.org/0000-0003-1412-4453 et al. (28 more authors) (2023) Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis. Arthritis & Rheumatology, 75 (9). pp. 1608-1618. ISSN 2326-5191

Matteson, E.L. orcid.org/0000-0002-9866-0124, Matucci-Cerinic, M. orcid.org/0000-0002-9324-3161, Kreuter, M. et al. (6 more authors) (2023) Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review. RMD Open, 9 (3). e003059. ISSN 2056-5933

Lescoat, A., Huang, S., Carreira, P.E. et al. (219 more authors) (2023) Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database. JAMA Dermatology, 159 (8). pp. 837-847. ISSN 2168-6068

Lepri, G., Hughes, M., Allanore, Y. et al. (8 more authors) (2023) The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution. The Lancet Rheumatology, 5 (7). e422-e425. ISSN 2665-9913

Denton, C.P. orcid.org/0000-0003-3975-8938, del Galdo, F. orcid.org/0000-0002-8528-2283, Khanna, D. et al. (12 more authors) (2023) Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis. Rheumatology, 62 (1). pp. 234-242. ISSN 1462-0324

Kakkar, V., Assassi, S., Allanore, Y. et al. (4 more authors) (2022) Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit. Current Opinion in Rheumatology, 34 (6). pp. 357-364. ISSN 1040-8711

Lescoat, A., Murphy, S.L., Chen, Y.T. et al. (5 more authors) (2022) Symptom experience of limited cutaneous systemic sclerosis from the Patients’ perspective: A qualitative study. Seminars in Arthritis and Rheumatism, 52. 151926. ISSN 0049-0172

Kreuter, M. orcid.org/0000-0003-4402-2159, Del Galdo, F. orcid.org/0000-0002-8528-2283, Miede, C. et al. (7 more authors) (2022) Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis. Arthritis Research & Therapy, 24. 19. ISSN 1478-6354

Abignano, G. orcid.org/0000-0002-1479-0133, Mennillo, G.A., Lettieri, G. orcid.org/0000-0002-7422-554X et al. (6 more authors) (2021) UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis. The Journal of Rheumatology, 48 (9). pp. 1422-1426. ISSN 0315-162X

Lescoat, A., Roofeh, D., Townsend, W. et al. (6 more authors) (2021) Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: a scoping review protocol. BMJ Open, 11 (3). e044765. ISSN 2044-6055

Lescoat, A., Murphy, S.L., Roofeh, D. et al. (17 more authors) (2020) Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes. Journal of Scleroderma and Related Disorders, 6 (1). 66 -76. ISSN 2397-1983

Conference or Workshop Item

Del Galdo, F. orcid.org/0000-0002-8528-2283, Khanna, D., Crater, C. et al. (6 more authors) (2023) AB0808 a proof of biological concept trial of CM101 to target CCL24 in systemic sclerosis: a biomarker informed, precision medicine approach. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Stock, C., Kreuter, M., Del Galdo, F. orcid.org/0000-0002-8528-2283 et al. (7 more authors) (2021) PRS3 Joint Modelling of Forced Vital Capacity Decline and Time to Hospitalization Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease. In: Virtual ISPOR 2021, 17-20 May 2021, Online.

Proceedings Paper

Del Galdo, F. orcid.org/0000-0002-8528-2283, Bissell, L.A., Huang, S. et al. (4 more authors) (2023) POS0338 Development And Validation Of Ranked Composite Important Difference (RCID) Score In Diffuse Cutaneous Systemic Sclerosis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 416.

Lescoat, A., Chen, Y., Murphy, S.L. et al. (22 more authors) (2023) POS1258 Results from a nominal group technique exercise for the creation of a combined response index for limited cutaneous systemic sclerosis: The CRISTAL project. In: Annals of the Rheumatic Diseases. EULAR 2023 - European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 971-972.